ASX 200 up 0.3%: Afterpay surges, Pro Medicus rockets on $40m contract, Whitehaven rises

Afterpay Ltd (ASX:APT) and Pro Medicus Limited (ASX:PME) shares are causing a stir on the ASX 200 on Thursday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Thursday the S&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. The benchmark index is currently up 0.3% to 6,708.3 points.

Here's what is happening on the market today:

Afterpay surges higher.

The Afterpay Ltd (ASX: APT) share price is back on form on Thursday and is surging higher. Improving sentiment in the tech sector and a positive broker note appear to be the drivers of this gain. In respect to the latter, this morning Morgan Stanley retained its overweight rating and lifted its price target on the payments company's shares to $136.00. The broker notes that app downloads have been increasing strongly in the US and UK.

Pro Medicus $40 million contract win.

The Pro Medicus Limited (ASX: PME) share price is rocketing higher today after the leading health imaging software company announced another major new contract win. Pro Medicus has signed a seven-year contract worth $40 million with Salt Lake City based Intermountain Healthcare. The deal will see its Visage 7 Viewer and Visage 7 Open Archive products implemented across all of Intermountain's radiology and subspecialty imaging departments.

Whitehaven Coal climbs higher.

The Whitehaven Coal Ltd (ASX: WHC) share price is climbing higher today following the release of its quarterly update. For the three months ended 31 December, Whitehaven Coal achieved a 64% increase in managed run-of-mine (ROM) production to 5.1Mt. And while its sales were flat on the prior corresponding period, management has tightened its guidance range to between 19Mt and 20Mt from 18.5Mt and 20Mt. The company also revealed that coal prices have been improving strongly.

Best and worst ASX 200 performers.

The best performer on the ASX 200 on Thursday has been the Pro Medicus share price. Its shares are up 12.5% following its $40 million contract win. The worst performer on the index has been the Abacus Property Group (ASX: ABP) share price with a decline of almost 5%. This is due largely to its shares trading ex-dividend today for its 8.5 cents per share interim dividend.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

5 mini houses on a pile of coins.
Opinions

2 ASX shares I'd much rather buy than an investment property

Certain ASX shares can offer exposure to real estate with more income potential.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A businessman wears armour and holds a shield and sword.
Share Market News

Nervous investors turn to ASX 200 defensives as global energy shock drags on

ASX investors sought safety in defensive sectors last week.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Share Market News

How much do I need to invest in ASX shares to earn a $500 monthly passive income?

A $500 per month passive income is more achievable than you'd think.

Read more »